Multi-epitope peptide melanoma vaccine with GM-CSF DNA adjuvant
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Multi-epitope peptide melanoma vaccine with GM-CSF DNA adjuvant, covering 2011-06-10 to 2011-06-10. Get the full timeline:
Most recent: Clinical Trial Update: Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity [EARLY_Phase 1]